| 1A9U | A:111-319 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580 |
| 1AD5 | A:345-519; B:345-519 | SRC FAMILY KINASE HCK-AMP-PNP COMPLEX |
| 1AGW | A:564-759; B:564-756 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR |
| 1AQ1 | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE |
| 1B38 | A:85-297 | HUMAN CYCLIN-DEPENDENT KINASE 2 |
| 1B39 | A:85-297 | HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 |
| 1B6C | B:285-500; D:285-500; F:285-500; H:285-500 | CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 |
| 1BI7 | A:103-299 | MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX |
| 1BI8 | A:103-299; C:103-299 | MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURES CDK6-P19INK4D INHIBITOR COMPLEX |
| 1BL6 | A:111-319 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995 |
| 1BL7 | A:111-319 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025 |
| 1BLX | A:103-299 | P19INK4D/CDK6 COMPLEX |
| 1BMK | A:111-319 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655 |
| 1BUH | A:85-293 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1 |
| 1BYG | A:269-445 | KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE |
| 1CKP | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B |
| 1CM8 | A:114-328; B:1114-1328 | PHOSPHORYLATED MAP KINASE P38-GAMMA |
| 1DI8 | A:85-296 | THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE |
| 1DI9 | A:111-319 | THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE |
| 1DM2 | A:85-296 | HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE |
| 1E1V | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 |
| 1E1X | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 |
| 1E9H | A:85-295; C:85-295 | THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND |
| 1F3M | C:347-542; D:347-541 | CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1 |
| 1F5Q | C:85-294; A:85-297 | CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2 |
| 1FGI | A:564-759; B:564-757 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR |
| 1FIN | A:85-297; C:85-297 | CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX |
| 1FMK | A:345-519 | CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC |
| 1FQ1 | B:85-295 | CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2 |
| 1FVR | A:905-1112; B:905-1112 | TIE2 KINASE DOMAIN |
| 1FVT | A:85-296 | THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH AN OXINDOLE INHIBITOR |
| 1FVV | A:85-297; C:85-297 | THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR |
| 1G3N | A:103-299; E:103-299 | STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX |
| 1G5S | A:85-296 | CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717 |
| 1GAG | A:1079-1281 | CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR |
| 1GIH | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR |
| 1GII | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR |
| 1GIJ | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR |
| 1GJO | A:567-762 | THE FGFR2 TYROSINE KINASE DOMAIN |
| 1GNG | A:137-383; B:137-383 | GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE |
| 1GZ8 | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE |
| 1GZK | A:236-429 | MOLECULAR MECHANISM FOR THE REGULATION OF PROTEIN KINASE B/ AKT BY HYDROPHOBIC MOTIF PHOSPHORYLATION |
| 1GZN | A:236-429 | STRUCTURE OF PKB KINASE DOMAIN |
| 1GZO | A:236-429 | STRUCTURE OF PROTEIN KINASE B UNPHOSPHORYLATED |
| 1H00 | A:85-295 | CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR |
| 1H01 | A:85-294 | CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR |
| 1H07 | A:85-294 | CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR |
| 1H08 | A:85-296 | CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR |
| 1H0V | A:85-296 | HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5'-YL]METHOXYPURINE |
| 1H0W | A:85-296 | HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[CYCLOHEX-3-ENYL]METHOXYPURINE |
| 1H1P | A:85-295; C:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058 |
| 1H1Q | A:85-295; C:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094 |
| 1H1R | A:85-295; C:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086 |
| 1H1S | A:85-295; C:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102 |
| 1H1W | A:166-357 | HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN |
| 1H24 | A:85-292; C:85-292 | CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F |
| 1H25 | C:85-291; A:85-292 | CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN |
| 1H26 | C:85-294; A:85-295 | CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53 |
| 1H27 | C:85-294; A:85-295 | CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27 |
| 1H28 | A:85-295; C:85-295 | CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107 |
| 1H4L | A:85-285; B:85-285 | STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX |
| 1H8F | A:137-383; B:137-383 | GLYCOGEN SYNTHASE KINASE 3 BETA. |
| 1HCK | A:85-297 | HUMAN CYCLIN-DEPENDENT KINASE 2 |
| 1HCL | A:85-297 | HUMAN CYCLIN-DEPENDENT KINASE 2 |
| 1I09 | A:137-382; B:137-382 | STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B) |
| 1I44 | A:1079-1282 | CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE |
| 1IA8 | A:98-276 | THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1 |
| 1IAS | B:285-500; A:285-500; C:285-500; D:285-500; E:285-500 | CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12 |
| 1IG1 | A:106-291 | 1.8A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MN. |
| 1IR3 | A:1079-1281 | PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG |
| 1IRK | A:1079-1283 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTOR |
| 1J1B | B:637-882; A:137-383 | BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP |
| 1J1C | B:637-882; A:137-383 | BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP |
| 1JKK | A:99-277 | 2.4A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MG. |
| 1JKL | A:106-291 | 1.6A X-RAY STRUCTURE OF BINARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE |
| 1JKS | A:99-291 | 1.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE |
| 1JKT | A:99-277; B:99-277 | TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE |
| 1JNK | A:151-370 | THE C-JUN N-TERMINAL KINASE (JNK3S) COMPLEXED WITH MGAMP-PNP |
| 1JQH | A:1079-1279; C:1079-1279; B:1079-1279 | IGF-1 RECEPTOR KINASE DOMAIN |
| 1JST | A:85-297; C:85-297 | PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A |
| 1JSU | A:85-297 | P27(KIP1)/CYCLIN A/CDK2 COMPLEX |
| 1JSV | A:85-297 | THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[(6-AMINO-4-PYRIMIDINYL) AMINO]BENZENESULFONAMIDE |
| 1JVP | P:87-293 | CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365 |
| 1JWH | A:7-24,A:116-333; B:7-24,B:116-333 | CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME |
| 1K2P | A:477-654; B:477-654 | CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN |
| 1K3A | A:1052-1253 | STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE |
| 1KE5 | A:85-296 | CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE |
| 1KE6 | A:85-296 | CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE |
| 1KE7 | A:85-296 | CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE |
| 1KE8 | A:85-296 | CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE |
| 1KE9 | A:85-296 | CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE |
| 1KSW | A:345-519 | STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP |
| 1KV1 | A:111-319 | P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1 |
| 1KV2 | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796 |
| 1KWP | B:141-365; A:141-365 | CRYSTAL STRUCTURE OF MAPKAP2 |
| 1M14 | A:769-982 | TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR |
| 1M17 | A:769-964 | EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB |
| 1M7N | A:1079-1280; B:1079-1280 | CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN |
| 1M7Q | A:111-319 | CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR |
| 1MP8 | A:502-684 | CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK) |
| 1MQ4 | A:217-387 | CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE |
| 1MQB | A:695-885; B:695-881 | CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE |
| 1MRV | A:236-429 | CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN |
| 1MRY | A:236-429 | CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN |
| 1MUO | A:217-387 | CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE |
| 1NA7 | A:7-24,A:116-329 | CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 |
| 1NVQ | A:98-273 | THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01 |
| 1NVR | A:98-273 | THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/STAUROSPORINE |
| 1NVS | A:98-273 | THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078 |
| 1NXK | C:141-344; A:141-332; B:141-332; D:141-329 | CRYSTAL STRUCTURE OF STAUROSPORINE BOUND TO MAP KAP KINASE 2 |
| 1NY3 | A:141-342 | CRYSTAL STRUCTURE OF ADP BOUND TO MAP KAP KINASE 2 |
| 1O6K | A:236-429 | STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP |
| 1O6L | A:236-429 | CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE |
| 1O9U | A:137-383 | GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE |
| 1OEC | A:567-762 | FGFR2 KINASE DOMAIN |
| 1OGU | C:85-294; A:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR |
| 1OI9 | A:85-295; C:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR |
| 1OIQ | A:85-294 | IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION |
| 1OIR | A:85-294 | IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION |
| 1OIT | A:85-295 | IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION |
| 1OIU | A:85-295; C:85-294 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR |
| 1OIY | A:85-295; C:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR |
| 1OKV | A:85-294; C:85-296 | CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2 |
| 1OKW | A:85-296; C:85-296 | CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2 |
| 1OKY | A:166-357 | STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE |
| 1OKZ | A:166-357 | STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01 |
| 1OL1 | A:85-296; C:85-296 | CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2 |
| 1OL2 | A:85-296; C:85-296 | CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2 |
| 1OL5 | A:217-386 | STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND BOUND TO TPX2 1-43 |
| 1OL6 | A:217-383 | STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A |
| 1OL7 | A:217-387 | STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288 |
| 1OPL | B:337-518; A:345-519 | STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE |
| 1OUK | A:111-319 | THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A PYRIDINYLIMIDAZOLE INHIBITOR |
| 1OUY | A:111-319 | THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO-PYRIMIDINE INHIBITOR |
| 1OVE | A:111-319 | THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROQUINOLINONE |
| 1OZ1 | A:111-319 | P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR |
| 1P14 | A:1079-1282 | CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE |
| 1P2A | A:85-295 | THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A TRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR |
| 1P4F | A:99-277 | DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT |
| 1P4O | A:1051-1255; B:1051-1255 | STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION. |
| 1P5E | A:85-295; C:85-295 | THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS) |
| 1PF8 | A:85-297 | CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR |
| 1PJK | A:7-24,A:116-331 | CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT |
| 1PKD | A:85-295; C:85-295 | THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A |
| 1PKG | A:673-924; B:673-925 | STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX |
| 1PME | A:108-338 | STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE |
| 1PMN | A:151-370 | CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR |
| 1PMQ | | [entry was replaced by entry 4Z9L without any CATH domain information] |
| 1PMU | A:151-370 | THE CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH A PHENANTROLINE INHIBITOR |
| 1PMV | A:151-370 | THE STRUCTURE OF JNK3 IN COMPLEX WITH A DIHYDROANTHRAPYRAZOLE INHIBITOR |
| 1PW2 | A:85-297 | APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 |
| 1PXI | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2-YLAMINE |
| 1PXJ | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINE |
| 1PXK | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'-HYDROXYIMINOFORMAMIDE |
| 1PXL | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL-PHENYL)-AMINE |
| 1PXM | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 3-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL |
| 1PXN | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL |
| 1PXO | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE |
| 1PXP | A:85-297 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE |
| 1PY5 | A:285-500 | CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR |
| 1PYE | A:85-294 | CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR |
| 1PYX | B:137-383; A:137-386 | GSK-3 BETA COMPLEXED WITH AMP-PNP |
| 1Q3D | A:137-355; B:137-355 | GSK-3 BETA COMPLEXED WITH STAUROSPORINE |
| 1Q3W | B:137-383; A:137-386 | GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE |
| 1Q41 | A:137-386; B:137-383 | GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME |
| 1Q4L | B:137-383; A:137-386 | GSK-3 BETA COMPLEXED WITH INHIBITOR I-5 |
| 1Q5K | B:137-384; A:137-384 | CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR |
| 1QCF | A:345-519 | CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR |
| 1QMZ | A:85-295; C:85-295 | PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX |
| 1QPC | A:319-499 | STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS |
| 1QPD | A:319-500 | STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS |
| 1QPE | A:319-500 | STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS |
| 1QPJ | A:319-500 | CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE. |
| 1R0E | A:137-383; B:137-383 | GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4-ARYLMALEIMIDE INHIBITOR |
| 1R0P | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A |
| 1R1W | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET |
| 1R39 | A:111-319 | THE STRUCTURE OF P38ALPHA |
| 1R3C | A:111-319 | THE STRUCTURE OF P38ALPHA C162S MUTANT |
| 1R78 | A:85-296 | CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR |
| 1RJB | A:696-947 | CRYSTAL STRUCTURE OF FLT3 |
| 1RQQ | A:1079-1281; B:1079-1281 | CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS |
| 1RW8 | A:285-500 | CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR |
| 1S9I | B:152-389; A:152-393 | X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP |
| 1S9J | A:147-382 | X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP |
| 1SM2 | A:440-619; B:440-617 | CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN |
| 1SNU | A:440-619; B:440-617 | CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN |
| 1SNX | A:440-619; B:440-619 | CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN |
| 1T45 | A:673-935 | STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE |
| 1T46 | A:673-924 | STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE |
| 1TKI | A:102-338; B:102-338 | AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN |
| 1TVO | A:108-336 | THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR |
| 1U46 | B:208-390; A:208-389 | CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1 |
| 1U4D | B:208-390; A:208-389 | STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE |
| 1U54 | B:208-388; A:208-390 | CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP |
| 1U59 | A:417-612 | CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE |
| 1UA2 | A:96-311; B:96-311; C:96-311; D:96-311 | CRYSTAL STRUCTURE OF HUMAN CDK7 |
| 1UKH | A:113-332 | STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125 |
| 1UKI | A:113-332 | STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125 |
| 1UNG | A:85-285; B:85-288 | STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN. |
| 1UNH | B:85-285; A:85-288 | STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN. |
| 1UNL | A:85-285; B:85-285 | STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN. |
| 1URC | A:85-296; C:85-296 | CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY |
| 1URW | A:85-295 | CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B]PYRIDAZINE |
| 1UU3 | A:166-357 | STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531 |
| 1UU7 | A:166-357 | STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2 |
| 1UU8 | A:166-357 | STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1 |
| 1UV5 | A:137-382 | GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME |
| 1UVR | A:166-357 | STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8 |
| 1UWH | A:533-722; B:533-722 | THE COMPLEX OF WILD TYPE B-RAF AND BAY439006 |
| 1UWJ | A:533-722; B:533-722 | THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006 |
| 1V1K | A:85-296 | CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR |
| 1VJY | A:285-500 | CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF-BETA TYPE I RECEPTOR |
| 1VR2 | A:919-1166 | HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN |
| 1VYW | A:85-297; C:85-297 | STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 |
| 1VYZ | A:85-296 | STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 |
| 1VZO | A:135-345 | THE STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF MSK1 REVEALS A NOVEL AUTOINHIBITORY CONFORMATION FOR A DUAL KINASE PROTEIN |
| 1W7H | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1W82 | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1W83 | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1W84 | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1W8C | A:85-297 | CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2 |
| 1W98 | A:85-295 | THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E |
| 1WAK | A:134-144,A:168-655 | X-RAY STRUCTURE OF SRPK1 |
| 1WBN | A:111-319 | FRAGMENT BASED P38 INHIBITORS |
| 1WBO | A:111-319 | FRAGMENT BASED P38 INHIBITORS |
| 1WBP | A:134-144,A:168-655 | SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE |
| 1WBS | A:111-319 | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WBT | A:111-319 | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WBV | A:111-319 | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WBW | A:111-319 | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WCC | A:85-296 | SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY |
| 1WFC | A:111-319 | STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN |
| 1WMK | A:99-276; C:98-304; F:98-304; H:96-305; E:96-314; G:96-314; B:96-315; D:96-315 | HUMAN DEATH-ASSOCIATED KINASE DRP-1, MUTANT S308D D40 |
| 1WVW | A:99-276 | CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS |
| 1WVX | A:99-276 | CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS |
| 1WVY | A:99-276 | CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS |
| 1WZY | A:108-336 | CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE |
| 1X8B | A:356-360,A:380-569 | STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824 |
| 1XBA | A:451-636 | CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN |
| 1XBB | A:451-639 | CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC |
| 1XBC | A:451-636 | CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN |
| 1XJD | A:465-696 | CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINE AT 2A RESOLUTION |
| 1XKK | A:793-987 | EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016 |
| 1XQZ | A:125-308 | CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION |
| 1XR1 | A:125-308 | CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNP AT 2.1 A RESOLUTION |
| 1XWS | A:125-305 | CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN |
| 1Y57 | A:345-523 | STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR |
| 1Y6A | A:917-1164 | CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR |
| 1Y6B | A:917-1164 | CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR |
| 1Y8Y | A:85-296 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR |
| 1Y91 | A:85-296 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR |
| 1YHS | A:125-305 | CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE |
| 1YHV | A:347-541 | CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH TWO POINT MUTATIONS (K299R, T423E) |
| 1YHW | A:347-541 | CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH ONE POINT MUTATIONS (K299R) |
| 1YI3 | A:125-305 | CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002 |
| 1YI4 | A:125-305 | STRUCTURE OF PIM-1 BOUND TO ADENOSINE |
| 1YI6 | A:343-533; B:343-533 | C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533) |
| 1YKR | A:85-296 | CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR |
| 1YOJ | A:345-535; B:346-525 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN |
| 1YOL | A:343-528; B:343-528 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675 |
| 1YOM | B:343-528; A:343-528 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A |
| 1YQJ | A:111-319 | CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A SELECTIVE PYRIDAZINE INHIBITOR |
| 1YRP | A:99-277; B:99-277 | CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265 |
| 1YVJ | A:905-1100 | CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE |
| 1YWN | A:917-1164 | VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE |
| 1YWV | A:125-306 | CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGET OF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELL LYMPHOMA |
| 1YXS | A:125-306 | CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION |
| 1YXT | A:125-306 | CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP |
| 1YXU | A:125-305; B:125-305; C:125-305; D:125-305 | CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP |
| 1YXV | A:125-306 | CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4-DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE |
| 1YXX | A:125-306 | CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE |
| 1Z57 | A:221-224,A:244-482 | CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH 10Z-HYMENIALDISINE |
| 1Z5M | A:166-357 | CRYSTAL STRUCTURE OF N1-[3-[[5-BROMO-2-[[3-[(1-PYRROLIDINYLCARBONYL) AMINO]PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]PROPYL]-2,2-DIMETHYLPROPANEDIAMIDE COMPLEXED WITH HUMAN PDK1 |
| 1Z9X | A:98-304; B:98-304; C:98-304 | HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT |
| 1ZLT | A:98-276 | CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINE ANALOG |
| 1ZRZ | A:326-532 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA |
| 1ZWS | A:99-279; B:99-279; C:99-279; D:99-279; E:99-279; F:99-279; G:99-279; H:99-279 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE |
| 1ZYJ | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A |
| 1ZYS | A:98-273 | CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR |
| 1ZZ2 | A:111-319 | TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING A COMMON DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDING MODES |
| 1ZZL | A:111-319 | CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE |
| 2A0C | X:85-296 | HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR |
| 2A27 | B:98-304; C:98-304; E:98-304; F:98-304; G:98-304; A:96-305; D:96-305; H:96-305 | HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT |
| 2A2A | A:98-304; B:98-304; C:98-304; D:98-304 | HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE |
| 2A4L | A:85-296 | HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE |
| 2AC3 | A:162-369 | STRUCTURE OF HUMAN MNK2 KINASE DOMAIN |
| 2AC5 | A:162-370 | STRUCTURE OF HUMAN MNK2 KINASE DOMAIN MUTANT D228G |
| 2ACX | B:270-468; A:270-468 | CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 6 BOUND TO AMPPNP |
| 2AUH | A:1079-1281 | CRYSTAL STRUCTURE OF THE GRB14 BPS REGION IN COMPLEX WITH THE INSULIN RECEPTOR TYROSINE KINASE |
| 2AYP | A:98-269 | CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR |
| 2B1P | A:151-370 | INHIBITOR COMPLEX OF JNK3 |
| 2B4S | B:1079-1281; D:1079-1281 | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE |
| 2B52 | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562 |
| 2B53 | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 |
| 2B54 | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN-232305 |
| 2B55 | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH INDENOPYRAXOLE DIN-101312 |
| 2B7A | A:932-1128; B:932-1128 | THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR |
| 2BAJ | A:111-319 | P38ALPHA BOUND TO PYRAZOLOUREA |
| 2BAK | A:111-319 | P38ALPHA MAP KINASE BOUND TO MPAQ |
| 2BAL | A:111-319 | P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE |
| 2BAQ | A:111-319 | P38ALPHA BOUND TO RO3201195 |
| 2BDF | B:343-528; A:343-528 | SRC KINASE IN COMPLEX WITH INHIBITOR AP23451 |
| 2BDJ | A:343-521 | SRC KINASE IN COMPLEX WITH INHIBITOR AP23464 |
| 2BHE | A:85-296 | HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO-INDIRUBINE |
| 2BHH | A:85-296 | HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4-HYDROXYPIPERINDINESULFONYL-INDIRUBINE |
| 2BIK | B:125-305 | HUMAN PIM1 PHOSPHORYLATED ON SER261 |
| 2BIL | B:125-306 | THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE PIMTIDE |
| 2BIY | A:166-357 | STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN |
| 2BKZ | A:85-297; C:85-297 | STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611 |
| 2BMC | A:217-387; B:217-387; C:217-387; D:217-387; E:217-387; F:217-387 | AURORA-2 T287D T288D COMPLEXED WITH PHA-680632 |
| 2BPM | A:85-297; C:85-297 | STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 |
| 2BR1 | A:98-276 | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRB | A:98-276 | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRG | A:98-269 | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRH | A:98-271 | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRM | A:98-274 | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRN | A:98-276 | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRO | A:98-276 | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BTR | A:85-296 | STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873 |
| 2BTS | A:85-296 | STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032 |
| 2BUJ | A:102-299; B:102-297 | CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE |
| 2BVA | A:398-587; B:398-587 | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 |
| 2BZH | B:125-306 | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1 |
| 2BZI | B:125-305 | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2 |
| 2BZJ | A:125-305 | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3 |
| 2C0I | A:319-493; B:319-493 | SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983 |
| 2C0O | A:319-493; B:319-493 | SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041 |
| 2C0T | A:319-493; B:319-493 | SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359 |
| 2C30 | A:484-674 | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 6 |
| 2C3J | A:98-270 | IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION |
| 2C3K | A:98-270 | IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION |
| 2C3L | A:98-273 | IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION |
| 2C47 | C:83-297; D:83-298; A:83-298; B:83-298 | STRUCTURE OF CASEIN KINASE 1 GAMMA 2 |
| 2C4G | A:85-297; C:85-297 | STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 |
| 2C5N | A:85-296; C:85-297 | DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN |
| 2C5O | A:85-296; C:85-297 | DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN |
| 2C5V | A:85-296; C:85-296 | DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN |
| 2C5X | A:85-296; C:85-296 | DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN |
| 2C5Y | A:85-296 | DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN |
| 2C68 | A:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2C69 | A:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2C6D | A:216-386 | AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP |
| 2C6E | A:216-388; B:216-387 | AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5-AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR |
| 2C6I | A:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2C6K | A:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2C6L | A:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2C6M | A:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2C6O | A:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2C6T | A:85-296; C:85-296 | CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR |
| 2CCH | A:85-295; C:85-295 | THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE |
| 2CCI | A:85-295; C:85-295 | CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 |
| 2CDZ | A:398-590 | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A |
| 2CGU | A:98-271 | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CGV | A:98-272 | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CGW | A:98-271 | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CGX | A:98-273 | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CHL | A:109-322 | STRUCTURE OF CASEIN KINASE 1 GAMMA 3 |
| 2CJM | A:85-292; C:85-297 | MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE |
| 2CKE | A:98-301; B:98-301; C:98-301; D:98-301 | HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR |
| 2CLX | A:85-296 | 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS |
| 2CMW | A:122-339 | STRUCTURE OF HUMAN CASEIN KINASE 1 GAMMA-1 IN COMPLEX WITH 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE (CASP TARGET) |
| 2CN5 | A:304-504 | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP |
| 2CN8 | A:304-503 | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH DEBROMOHYMENIALDISINE |
| 2DQ7 | X:87-263 | CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAUROSPORINE |
| 2DS1 | A:85-296 | HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR |
| 2DUV | A:85-296 | STRUCTURE OF CDK2 WITH A 3-HYDROXYCHROMONES |
| 2DWB | A:217-383 | AURORA-A KINASE COMPLEXED WITH AMPPNP |
| 2DYL | A:216-418 | CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 ACTIVATED MUTANT (S287D, T291D) |
| 2E14 | | [entry was replaced by entry 3W55 without any CATH domain information] |
| 2E2B | A:318-497; B:318-497 | CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406 |
| 2E9N | A:98-270 | STRUCTURE OF H-CHK1 COMPLEXED WITH A767085 |
| 2E9O | A:98-270 | STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939 |
| 2E9P | A:98-270 | STRUCTURE OF H-CHK1 COMPLEXED WITH A771129 |
| 2E9U | A:98-270 | STRUCTURE OF H-CHK1 COMPLEXED WITH A780125 |
| 2E9V | A:98-269; B:98-269 | STRUCTURE OF H-CHK1 COMPLEXED WITH A859017 |
| 2EB2 | A:793-990 | CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (G719S) |
| 2EB3 | A:793-990 | CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (L858R) IN COMPLEX WITH AMPPNP |
| 2ESM | A:160-358; B:160-358 | CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL |
| 2ETK | A:160-358; B:160-358 | CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL |
| 2ETM | A:502-684; B:502-684 | CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [2,3-D] PYRIMIDINE DERIVATIVE |
| 2ETR | A:160-358; B:160-358 | CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632 |
| 2EU9 | A:216-219,A:239-481 | CRYSTAL STRUCTURE OF CLK3 |
| 2EVA | A:109-497 | STRUCTURAL BASIS FOR THE INTERACTION OF TAK1 KINASE WITH ITS ACTIVATING PROTEIN TAB1 |
| 2EXC | X:151-370 | INHIBITOR COMPLEX OF JNK3 |
| 2EXE | A:198-479 | CRYSTAL STRUCTURE OF THE PHOSPHORYLATED CLK3 |
| 2EXM | A:85-296 | HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE |
| 2F4J | A:318-499 | STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680 |
| 2F57 | B:526-718; A:526-715 | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5 |
| 2FB8 | A:534-720; B:534-720 | STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885 |
| 2FGI | A:564-757; B:564-757 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074 |
| 2FO0 | A:337-530 | ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE |
| 2FSL | X:111-319 | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-A |
| 2FSM | X:111-319 | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-B |
| 2FSO | X:111-319 | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A) ACTIVATING MUTANT |
| 2FST | X:111-319 | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327L) ACTIVATING MUTANT |
| 2FVD | A:85-296 | CYCLIN DEPENDENT KINASE 2 (CDK2) WITH DIAMINOPYRIMIDINE INHIBITOR |
| 2G01 | A:113-332; B:113-332 | PYRAZOLOQUINOLONES AS NOVEL, SELECTIVE JNK1 INHIBITORS |
| 2G15 | A:1160-1346 | STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE |
| 2G1T | A:318-499; B:318-499; C:318-499; D:318-499 | A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN |
| 2G2F | A:318-499; B:318-499 | A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN |
| 2G2H | A:337-518; B:337-518 | A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN |
| 2G2I | A:318-499; B:318-499 | A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN |
| 2G9X | C:85-294; A:85-295 | STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271 |
| 2GDO | A:98-273 | 4-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS |
| 2GFS | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3201195 |
| 2GHG | A:98-270 | H-CHK1 COMPLEXED WITH A431994 |
| 2GMX | A:113-332; B:113-332 | SELECTIVE AMINOPYRIDINE-BASED C-JUN N-TERMINAL KINASE INHIBITORS WITH CELLULAR ACTIVITY |
| 2GQG | A:318-500; B:318-499 | X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN |
| 2GS2 | A:769-966 | CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN |
| 2GS6 | A:769-967 | CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AN ATP ANALOG-PEPTIDE CONJUGATE |
| 2GS7 | B:769-959; A:769-959 | CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP |
| 2GSF | A:702-904 | THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION |
| 2GU8 | A:14-32,A:127-317 | DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES |
| 2H6D | A:96-278 | PROTEIN KINASE DOMAIN OF THE HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (AMPK ALPHA-2 CHAIN) |
| 2H8H | A:345-519 | SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR |
| 2H96 | A:113-332; B:113-332 | DISCOVERY OF POTENT, HIGHLY SELECTIVE, AND ORALLY BIOAVAILABLE PYRIDINE CARBOXAMIDE C-JUN NH2-TERMINAL KINASE INHIBITORS |
| 2HAK | E:132-321; F:132-321; A:132-321; C:132-321; D:132-321; G:132-321; B:132-321; H:136-316 | CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK1/PAR-1 |
| 2HCK | A:345-519; B:345-519 | SRC FAMILY KINASE HCK-QUERCETIN COMPLEX |
| 2HIW | A:336-517; B:336-517 | CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR |
| 2HK5 | A:319-497 | HCK KINASE IN COMPLEX WITH LCK TARGETTED INHIBITOR PG-1009247 |
| 2HOG | A:98-280 | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 20 |
| 2HW6 | A:127-335; B:127-334 | CRYSTAL STRUCTURE OF MNK1 CATALYTIC DOMAIN |
| 2HW7 | A:162-371 | CRYSTAL STRUCTURE OF MNK2-D228G IN COMPLEX WITH STAUROSPORINE |
| 2HXL | A:98-276 | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1 |
| 2HXQ | A:98-276 | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2 |
| 2HY0 | A:98-280 | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 22 |
| 2HY8 | 1:347-541 | PAK1 COMPLEX WITH ST2001 |
| 2HYY | A:318-498; B:318-498; D:318-498; C:318-498 | HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571, GLIVEC) |
| 2HZ0 | A:318-497; B:318-497 | ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082 |
| 2HZ4 | A:318-500; C:318-500; B:318-498 | ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE |
| 2HZI | A:318-500; B:318-500 | ABL KINASE DOMAIN IN COMPLEX WITH PD180970 |
| 2I0E | B:423-619; A:427-620 | STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR |
| 2I0H | A:111-319 | THE STRUCTURE OF P38ALPHA IN COMPLEX WITH AN ARYLPYRIDAZINONE |
| 2I0V | A:666-910 | C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR |
| 2I0Y | A:666-910 | CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR |
| 2I1M | A:666-910 | CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR |
| 2I40 | A:85-296; C:85-296 | CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR |
| 2I6L | B:113-320; A:113-321 | CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6) |
| 2IJM | A:502-684; B:502-684 | CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP |
| 2IN6 | A:356-360,A:380-569 | WEE1 KINASE COMPLEX WITH INHIBITOR PD311839 |
| 2IO6 | A:356-360,A:380-569 | WEE1 KINASE COMPLEXED WITH INHIBITOR PD330961 |
| 2ITP | A:793-1004 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788 |
| 2ITT | A:793-987 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788 |
| 2ITV | A:793-987 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP |
| 2ITW | A:793-984 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941 |
| 2ITX | A:793-989 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP |
| 2ITZ | A:793-987 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA |
| 2IVS | A:807-1010; B:807-1010 | CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN |
| 2IVT | A:807-1010 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN |
| 2IVU | A:807-1010 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474 |
| 2IVV | A:807-1010 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR PP1 |
| 2IW6 | A:85-295; C:85-295 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR |
| 2IW8 | A:85-295; C:85-294 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR |
| 2IW9 | C:85-294; A:85-297 | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR |
| 2IWI | A:121-288; B:121-287 | CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1 |
| 2IZR | A:120-334 | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2IZS | A:120-333 | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2IZT | A:120-334 | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2IZU | A:120-334 | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2J0I | A:398-589 | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 |
| 2J2I | B:125-305 | CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531 |
| 2J4Z | A:217-387; B:217-387 | STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626 |
| 2J50 | A:217-387; B:217-387 | STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-739358 |
| 2J51 | A:111-308 | CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 5-AMINO-3-((4-(AMINOSULFONYL)PHENYL)AMINO)-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE |
| 2J5E | A:793-989 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB |
| 2J5F | A:793-991 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB |
| 2J6M | A:793-1004 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788 |
| 2J7T | A:113-317 | CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO SU11274 |
| 2J90 | B:99-280; A:99-278 | CRYSTAL STRUCTURE OF HUMAN ZIP KINASE IN COMPLEX WITH A TETRACYCLIC PYRIDONE INHIBITOR (PYRIDONE 6) |
| 2J9M | A:85-296 | CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE |
| 2JAM | B:101-302; A:101-303 | CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G |
| 2JAV | A:46-68,A:90-279 | HUMAN KINASE WITH PYRROLE-INDOLINONE LIGAND |
| 2JBO | A:141-342 | PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-1, SOAKING) |
| 2JBP | B:141-342; I:141-342; D:141-342; F:141-342; G:141-342; E:141-342; H:141-342; C:141-342; A:141-342; K:141-342; L:141-342; J:141-325 | PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION) |
| 2JC6 | A:101-279; C:101-279 | CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D |
| 2JDO | A:236-429 | STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE |
| 2JDR | A:236-429 | STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654 |
| 2JED | B:464-658; A:465-654 | THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION. |
| 2JFL | A:111-308 | CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE ( DIPHOSPHORYLATED FORM) BOUND TO 5- AMINO-3-((4-( AMINOSULFONYL)PHENYL)AMINO)-N-(2,6- DIFLUOROPHENYL)-1H-1,2, 4-TRIAZOLE-1-CARBOTHIOAMIDE |
| 2JFM | A:111-308 | CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE (UNLIGANDED FORM) |
| 2JGZ | A:85-288 | CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B |
| 2JII | A:262-461; B:262-461 | STRUCTURE OF VACCINIA RELATED KINASE 3 |
| 2JIT | A:793-1010; B:793-1010 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION |
| 2JIU | B:793-992; A:793-1010 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788 |
| 2JIV | B:793-982; A:793-984 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272 |
| 2JLD | A:137-355; B:137-384 | EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3 |
| 2NO3 | A:113-332; B:113-332 | NOVEL 4-ANILINOPYRIMIDINES AS POTENT JNK1 INHIBITORS |
| 2NPQ | A:111-319 | A NOVEL LIPID BINDING SITE IN THE P38 ALPHA MAP KINASE |
| 2NRU | A:265-458; B:265-458; C:265-458; D:265-458 | CRYSTAL STRUCTURE OF IRAK-4 |
| 2NRY | D:265-460; C:265-458; A:265-458; B:265-458 | CRYSTAL STRUCTURE OF IRAK-4 |
| 2O0U | A:151-363 | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-{3-CYANO-6-[3-(1-PIPERIDINYL)PROPANOYL]-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDIN-2-YL}-1-NAPHTHALENECARBOXAMIDE |
| 2O2U | A:151-363 | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-CYANO-4,5,6,7-TETRAHYDRO-1-BENZOTHIEN-2-YL)-2-FLUOROBENZAMIDE |
| 2O3P | A:125-306 | CRYSTAL STRUCTURE OF PIM1 WITH QUERCETIN |
| 2O5K | A:137-384 | CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL INHIBITOR |
| 2O63 | A:125-306 | CRYSTAL STRUCTURE OF PIM1 WITH MYRICETIN |
| 2O64 | A:125-306 | CRYSTAL STRUCTURE OF PIM1 WITH QUERCETAGETIN |
| 2O65 | A:125-306 | CRYSTAL STRUCTURE OF PIM1 WITH PENTAHYDROXYFLAVONE |
| 2O8Y | B:266-459; A:266-459 | APO IRAK4 KINASE DOMAIN |
| 2OBJ | A:125-305 | CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR |
| 2OF2 | A:319-500 | CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK |
| 2OF4 | A:319-500 | CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK |
| 2OFU | A:319-500 | X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK |
| 2OFV | A:321-498; B:321-499 | CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK |
| 2OG8 | B:321-500; A:321-499 | CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK |
| 2OGV | A:666-910 | CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN |
| 2OH4 | A:917-1164 | CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR |
| 2OI4 | X:125-306 | CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH FLUORINATED RUTHENIUM PYRIDOCARBAZOLE |
| 2OIB | D:265-459; B:265-459; A:265-458; C:265-458 | CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM |
| 2OIC | D:265-459; B:265-459; A:265-458; C:265-458 | CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH STAUROSPORINE |
| 2OID | D:265-459; A:265-458; B:265-459; C:265-458 | CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH AMPPNP |
| 2OJ9 | A:1049-1249 | STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR |
| 2OJG | A:106-336 | CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 2OJI | A:106-336 | CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 2OJJ | A:106-336 | CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 2OK1 | A:151-370 | CRYSTAL STRUCTURE OF JNK3 BOUND TO N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 2OKR | D:111-319; A:111-319 | CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER |
| 2ONL | A:111-319; C:143-332; D:143-332; B:111-319 | CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER |
| 2OO8 | X:908-1117 | SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS |
| 2OSC | A:908-1116 | SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS |
| 2OU7 | A:137-309 | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1 |
| 2OW3 | A:137-385; B:137-386 | GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS-(INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR |
| 2OWB | A:137-309 | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1 |
| 2OZA | B:111-319; A:143-332 | STRUCTURE OF P38ALPHA COMPLEX |
| 2OZO | A:419-602 | AUTOINHIBITED INTACT HUMAN ZAP-70 |
| 2P0C | A:674-859; B:674-859 | CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER |
| 2P2H | A:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR |
| 2P2I | A:919-1166; B:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR |
| 2P33 | A:151-363 | SYNTHESIS AND SAR OF AMINOPYRIMIDINES AS NOVEL C-JUN N-TERMINAL KINASE (JNK) INHIBITORS |
| 2P3G | X:141-364 | CRYSTAL STRUCTURE OF A PYRROLOPYRIDINE INHIBITOR BOUND TO MAPKAP KINASE-2 |
| 2P4I | B:908-1117; A:908-1117 | EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR |
| 2P55 | A:147-382 | X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP |
| 2PE0 | A:166-357 | CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-HYDROXY-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-1,3-DIHYDRO-INDOL-2-ONE COMPLEX |
| 2PE1 | A:166-357 | CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-OXO-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOL-5-YL}-UREA {BX-517} COMPLEX |
| 2PE2 | A:166-357 | CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-OXO-5-UREIDO-1,2-DIHYDRO-INDOL-(3Z)-YLIDENEMETHYL]-1H-PYRROL-3-YL}-N-(2-PIPERIDIN-1-YL-ETHYL)-BENZAMIDE COMPLEX |
| 2PKJ | | [entry was replaced by entry 3MH0 without any CATH domain information] |
| 2PL0 | A:319-498 | LCK BOUND TO IMATINIB |
| 2PSQ | A:567-762; B:567-762 | CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN |
| 2PTJ | | [entry was replaced by entry 3MH3 without any CATH domain information] |
| 2PTO | | [entry was replaced by entry 3MH2 without any CATH domain information] |
| 2PV5 | | [entry was replaced by entry 3MGY without any CATH domain information] |
| 2PV8 | | [entry was replaced by entry 3MH1 without any CATH domain information] |
| 2PVF | A:567-762 | CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE |
| 2PVR | A:7-24,A:116-329 | CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 (C-TERMINAL DELETION MUTANT 1-335) IN COMPLEX WITH TWO SULFATE IONS |
| 2PVY | A:567-762; D:567-762; B:567-762; C:567-762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME. |
| 2PWL | B:567-762; A:567-762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME. |
| 2PY3 | B:567-762; A:567-762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
| 2PZ5 | A:567-762; B:567-762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
| 2PZP | B:567-762; A:567-762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME |
| 2PZR | A:567-762; B:567-762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
| 2PZY | C:141-342; D:141-342; A:141-342; B:141-342 | STRUCTURE OF MK2 COMPLEXED WITH COMPOUND 76 |
| 2Q0B | B:567-762; A:567-762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
| 2Q0N | A:398-591 | STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE |
| 2QD9 | A:111-319 | P38 ALPHA MAP KINASE INHIBITOR BASED ON HETEROBICYCLIC SCAFFOLDS |
| 2QHM | A:98-280 | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2A |
| 2QHN | A:98-280 | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1A |
| 2QLU | A:270-484 | CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE II KINASE DOMAIN FROM HUMAN |
| 2QNJ | B:135-324; A:135-324 | KINASE AND UBIQUITIN-ASSOCIATED DOMAINS OF MARK3/PAR-1 |
| 2QO2 | A:702-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO STRUCTURE |
| 2QO7 | A:702-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP-PNP BOUND |
| 2QO9 | A:703-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP-PNP BOUND |
| 2QOB | A:703-906 | HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE |
| 2QOC | A:703-906 | HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE |
| 2QOD | A:702-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT |
| 2QOF | A:702-906 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT |
| 2QOI | A:702-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F DOUBLE MUTANT |
| 2QOK | A:702-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A TRIPLE MUTANT |
| 2QOL | A:702-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596:Y602:S768G TRIPLE MUTANT |
| 2QON | A:702-905 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE MUTANT |
| 2QOO | A:702-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F TRIPLE MUTANT |
| 2QOQ | A:702-906 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND STRUCTURE |
| 2QU5 | A:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR |
| 2QU6 | A:919-1166; B:919-1165 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR |
| 2R0U | A:98-280 | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 54 |
| 2R2P | A:756-946 | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5) |
| 2R3F | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3G | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3H | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3I | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3J | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3K | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3L | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3M | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3N | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3O | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3P | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3Q | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R3R | A:85-296 | CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR |
| 2R4B | A:799-978; B:799-978 | ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR |
| 2R5T | A:183-372 | CRYSTAL STRUCTURE OF INACTIVE SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH AMP-PNP |
| 2R7B | A:166-357 | CRYSTAL STRUCTURE OF THE PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK-1)CATALYTIC DOMAIN BOUND TO A DIBENZONAPHTHYRIDINE INHIBITOR |
| 2R9S | A:151-380; B:151-380 | C-JUN N-TERMINAL KINASE 3 WITH 3,5-DISUBSTITUTED QUINOLINE INHIBITOR |
| 2REI | A:714-902 | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) |
| 2RF9 | A:769-959; B:769-961 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE |
| 2RFD | B:769-965; A:769-965 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE |
| 2RFE | A:769-968; D:769-985; B:769-959; C:769-959 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE |
| 2RFN | A:1160-1351; B:1160-1351 | X-RAY STRUCTURE OF C-MET WITH INHIBITOR. |
| 2RFS | A:1160-1346 | X-RAY STRUCTURE OF SU11274 BOUND TO C-MET |
| 2RG5 | A:111-319 | PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11B |
| 2RG6 | A:111-319 | PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11J |
| 2RGP | A:793-987 | STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR |
| 2RKU | A:137-309 | STRUCTURE OF PLK1 IN COMPLEX WITH BI2536 |
| 2RL5 | A:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A 2,3-DIHYDRO-1,4-BENZOXAZINE INHIBITOR |
| 2SRC | A:345-519 | CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP |
| 2UUE | A:85-296; C:85-297 | REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS |
| 2UV2 | A:111-308 | CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 4-(4-( 5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)-QUINAZOLIN-2-YLAMINO)-PHENYL)-ACETONITRILE |
| 2UW9 | A:236-429 | STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE |
| 2UZB | A:85-296; C:85-296 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR |
| 2UZD | A:85-296; C:85-296 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR |
| 2UZE | A:85-296; C:85-297 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR |
| 2UZL | A:85-297; C:85-297 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR |
| 2UZN | A:85-296 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR |
| 2UZO | A:85-296 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR |
| 2V0D | A:85-296 | CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR |
| 2V22 | A:85-296; C:85-297 | REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS |
| 2V55 | A:160-358; C:160-358 | MECHANISM OF MULTI-SITE PHOSPHORYLATION FROM A ROCK-I:RHOE COMPLEX STRUCTURE |
| 2V5Q | A:137-309; B:137-309 | CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN |
| 2V7A | A:318-499; B:318-499 | CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358 |
| 2V7O | A:95-302 | CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA |
| 2VAG | A:221-224,A:244-481 | CRYSTAL STRUCTURE OF DI-PHOSPHORYLATED HUMAN CLK1 IN COMPLEX WITH A NOVEL SUBSTITUTED INDOLE INHIBITOR |
| 2VD5 | B:155-362; A:155-357 | STRUCTURE OF HUMAN MYOTONIC DYSTROPHY PROTEIN KINASE IN COMPLEX WITH THE BISINDOYLMALEIDE INHIBITOR BIM VIII |
| 2VN9 | A:93-309; B:93-309 | CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1, CAMKD |
| 2VTA | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTH | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN |
| 2VTI | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTJ | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTL | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTM | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTN | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTO | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTP | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTQ | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTR | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTS | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VTT | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VU3 | A:85-296 | IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. |
| 2VV9 | A:85-296 | CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE |
| 2VWU | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWV | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWW | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWX | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWY | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWZ | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VX0 | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VX1 | A:696-884 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VZ6 | A:92-299; B:92-300 | STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804 |
| 2W05 | A:85-296 | STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5B |
| 2W06 | A:85-296 | STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5C |
| 2W0J | A:304-510 | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC INHIBITOR |
| 2W17 | A:85-296 | CDK2 IN COMPLEX WITH THE IMIDAZOLE PYRIMIDINE AMIDE, COMPOUND (S)-8B |
| 2W1C | A:217-387 | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1D | A:217-387 | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1E | A:217-387 | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1F | A:217-387 | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1G | A:217-387 | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1H | A:85-296 | FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4-YL UREA (AT9283), A MULTI-TARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE ACTIVITY |
| 2W4J | A:99-277 | X-RAY STRUCTURE OF A DAP-KINASE 2-277 |
| 2W4K | A:98-302 | X-RAY STRUCTURE OF A DAP-KINASE 2-302 |
| 2W4O | A:121-300 | CRYSTAL STRUCTURE OF HUMAN CAMK4 IN COMPLEX WITH 4-AMINO( SULFAMOYL-PHENYLAMINO)-TRIAZOLE-CARBOTHIOIC ACID (2,6-DIFLUORO-PHENYL)-AMIDE) |
| 2W5A | A:46-68,A:90-279 | HUMAN NEK2 KINASE ADP-BOUND |
| 2W5B | A:46-68,A:90-279 | HUMAN NEK2 KINASE ATPGAMMAS-BOUND |
| 2W5H | A:48-68,A:90-279 | HUMAN NEK2 KINASE APO |
| 2W7X | A:304-510 | CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 |
| 2W96 | B:98-294 | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2W99 | B:98-294 | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2W9F | B:98-294 | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2W9Z | B:98-294 | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2WAJ | A:151-368 | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH A 1-ARYL-3,4-DIHYDROISOQUINOLINE INHIBITOR |
| 2WD1 | A:1160-1346 | HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR |
| 2WEL | A:94-276 | CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN |
| 2WEV | A:85-296; C:85-297 | TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN |
| 2WFY | A:85-296; C:85-297 | TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN |
| 2WGJ | A:1160-1345 | X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET |
| 2WHB | A:85-296; C:85-297 | TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN |
| 2WIH | A:85-297; C:85-297 | STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 |
| 2WIP | C:85-296; A:85-297 | STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID |
| 2WKM | A:1160-1345 | X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET |
| 2WMQ | A:98-269 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMR | A:98-270 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMS | A:98-270 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMT | A:98-270 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMU | A:98-270 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMV | A:98-270 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMW | A:98-269 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMX | A:98-269 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WOT | A:285-500 | ALK5 IN COMPLEX WITH 4-((5,6-DIMETHYL-2-(2-PYRIDYL)-3-PYRIDYL)OXY)-N-(3,4,5-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE |
| 2WOU | A:285-496 | ALK5 IN COMPLEX WITH 4-((4-((2,6-DIMETHYL-3-PYRIDYL)OXY)-2-PYRIDYL)AMINO)BENZENESULFONAMIDE |
| 2WPA | A:85-297; C:85-297 | OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING |
| 2WQB | A:905-1112 | STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR |
| 2WQM | A:73-95,A:115-300 | STRUCTURE OF APO HUMAN NEK7 |
| 2WQN | A:73-95,A:115-300 | STRUCTURE OF ADP-BOUND HUMAN NEK7 |
| 2WQO | A:46-68,A:90-279 | STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950 |
| 2WTC | A:304-512 | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTD | A:304-512 | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTI | A:304-512 | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTJ | A:304-512 | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTV | A:217-386; B:217-386; C:217-386; D:217-386 | AURORA-A INHIBITOR STRUCTURE |
| 2WTW | A:217-386 | AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL FORM) |
| 2WU6 | A:216-219,A:239-483 | CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH DKI |
| 2WU7 | A:216-219,A:239-482 | CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH V25 |
| 2WXV | A:85-297; C:85-297 | STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR |
| 2X0G | A:96-320 | X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX |
| 2X1N | A:85-296; C:85-297 | TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN |
| 2X2K | A:807-1010 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
| 2X2L | A:807-1010 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
| 2X2M | A:807-1010; B:807-1010 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
| 2X39 | A:236-429 | STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB |
| 2X6D | A:217-386 | AURORA-A BOUND TO AN INHIBITOR |
| 2X6E | A:217-386 | AURORA-A BOUND TO AN INHIBITOR |
| 2X7G | A:146-156,A:180-699 | STRUCTURE OF HUMAN SERINE-ARGININE-RICH PROTEIN-SPECIFIC KINASE 2 (SRPK2) BOUND TO PURVALANOL B |
| 2X81 | A:217-387 | STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054 |
| 2X8D | A:98-281 | DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION |
| 2X8E | A:98-270 | DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION |
| 2X8I | A:98-269 | DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION |
| 2XB7 | A:1199-1389 | STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP-TAE684 |
| 2XBA | A:1199-1389 | STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429 |
| 2XCH | A:166-357 | CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR |
| 2XCK | A:166-357 | CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR |
| 2XEY | A:98-269 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2XEZ | A:98-270 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2XF0 | A:98-270 | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2XH5 | A:236-429 | STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDIN-4-AMINE BOUND TO PKB |
| 2XNE | A:217-387 | STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR |
| 2XNG | A:217-386 | STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR |
| 2XP2 | A:1199-1389 | STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066) |
| 2YWP | A:98-270 | CRYSTAL STRUCTURE OF CHK1 WITH A UREA INHIBITOR |
| 2YZA | A:96-278 | CRYSTAL STRUCTURE OF KINASE DOMAIN OF HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE ALPHA-2 SUBUNIT MUTANT (T172D) |
| 2Z2W | A:356-360,A:380-571 | HUMAN WEE1 KINASE COMPLEXED WITH INHIBITOR PF0335770 |
| 2Z7Q | A:148-340 | CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK-1 BOUND TO AMP-PCP |
| 2Z7R | A:148-340 | CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO STAUROSPORINE |
| 2Z7S | A:148-340 | CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO PURVALNOL A |
| 2Z8C | A:1079-1281 | PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2-YL]AMINO}PHENYL)ACETIC ACID |
| 2ZAZ | A:111-319 | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH 4-ANILINO QUINOLINE INHIBITOR |
| 2ZB0 | A:111-319 | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR |
| 2ZB1 | A:111-319 | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR |
| 2ZDT | A:151-368 | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR |
| 2ZDU | A:151-368 | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR |
| 2ZJW | A:7-24,A:116-331 | CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID |
| 2ZM1 | A:319-501 | CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 2ZM3 | A:1079-1279; B:1079-1279; C:1079-1279; D:1079-1279 | COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR |
| 2ZM4 | A:319-501 | CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) |
| 2ZOQ | A:125-355; B:125-355 | STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1 |
| 2ZV2 | A:271-449 | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA, CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609 |
| 2ZYB | A:319-501 | CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3A2C | F:141-342; D:141-342; C:141-342; E:141-342; H:141-342; I:141-342; J:141-342; L:141-342; B:141-342; G:141-342; A:141-342; K:141-342 | CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2) |
| 3A4O | X:91-274 | LYN KINASE DOMAIN |
| 3A4P | A:1160-1357 | HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR |
| 3A60 | B:179-372; A:179-371 | CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM I) |
| 3A61 | A:179-371 | CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM II) |
| 3A62 | A:179-372 | CRYSTAL STRUCTURE OF PHOSPHORYLATED P70S6K1 |
| 3A8W | A:330-533; B:330-533 | CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN |
| 3A8X | B:330-533; A:330-533 | CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN |
| 3AC1 | A:319-502 | CRYSTAL STRUCTURE OF PYRAZIN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3AC2 | A:319-502 | CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3AC3 | A:319-502 | CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3AC4 | A:319-502 | CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3AC5 | A:319-502 | CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3AC8 | A:319-501 | CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3ACJ | A:319-502 | CRYSTAL STRUCTURE OF IMIDAZO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3ACK | A:319-502 | CRYSTAL STRUCTURE OF PYRROLO PYRAZINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
| 3B2T | A:567-759; B:567-759 | STRUCTURE OF PHOSPHOTRANSFERASE |
| 3B2W | A:321-500 | CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK |
| 3B8Q | A:919-1166; B:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR |
| 3B8R | A:919-1166; B:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR |
| 3BBT | B:774-973; D:774-963 | CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB |
| 3BBW | B:774-973; A:774-966 | CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN ITS INACTIVE CONFORMATION |
| 3BCE | B:774-968; A:774-966; C:774-965 | CRYSTAL STRUCTURE OF THE ERBB4 KINASE |
| 3BE2 | A:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZAMIDE INHIBITOR |
| 3BEA | A:666-910 | CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR |
| 3BEG | A:134-144,A:168-655 | CRYSTAL STRUCTURE OF SR PROTEIN KINASE 1 COMPLEXED TO ITS SUBSTRATE ASF/SF2 |
| 3BEL | A:793-986 | X-RAY STRUCTURE OF EGFR IN COMPLEX WITH OXIME INHIBITOR |
| 3BGP | A:125-305 | HUMAN PIM-1 COMPLEXED WITH A BENZOISOXAZOLE INHIBITOR VX1 |
| 3BGQ | A:125-305 | HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE INHIBITOR VX2 |
| 3BGZ | A:125-305 | HUMAN PIM-1 KINASE IN COMPLEX WITH DIPHENYL INDOLE INHIBITOR VX3 |
| 3BHH | C:93-300; A:93-301; B:93-301; D:93-301 | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B) |
| 3BHT | C:85-294; A:85-295 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3 |
| 3BHU | C:85-294; A:85-295 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5 |
| 3BHV | C:85-294; A:85-295 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B |
| 3BHY | A:99-283 | CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH A BETA-CARBOLINE LIGAND |
| 3BI6 | A:356-360,A:380-570 | WEE1 KINASE COMPLEX WITH INHIBITOR PD352396 |
| 3BIZ | A:356-361,A:380-569 | WEE1 KINASE COMPLEX WITH INHIBITOR PD331618 |
| 3BKB | A:643-821 | CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) |
| 3BLH | A:108-325 | CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 |
| 3BLQ | A:108-325 | CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP |
| 3BLR | A:108-326 | CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH FLAVOPIRIDOL |
| 3BPR | A:674-859; B:674-859; C:674-859; D:674-859 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52 |
| 3BQC | A:7-24,A:116-330 | HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 |
| 3BQR | A:99-284 | CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH AN IMIDAZO-PYRIDAZINE LIGAND |
| 3BRB | A:674-859; B:674-859 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH ADP |
| 3BU3 | A:1079-1281 | CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE |
| 3BU5 | A:1079-1281 | CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP |
| 3BU6 | A:1079-1281 | CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE |
| 3BV2 | A:111-319 | MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 30 |
| 3BV3 | A:111-319 | MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 2 |
| 3BWF | A:125-305 | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AN OSMIUM COMPOUND |
| 3BX5 | A:111-319 | P38 ALPHA MAP KINASE COMPLEXED WITH BMS-640994 |
| 3BYM | A:319-500 | X-RAY CO-CRYSTAL STRUCTURE AMINOBENZIMIDAZOLE TRIAZINE 1 BOUND TO LCK |
| 3BYO | A:319-500 | X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5', 4':5,6]PYRIMIDO[1,2-A]BENZIMIDAZOL-5(6H)-ONE 25 BOUND TO LCK |
| 3BYS | A:321-501 | CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE AMIDE 10B |
| 3BYU | A:321-501 | CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMIDE 23 |
| 3BZ3 | A:502-684 | CRYSTAL STRUCTURE ANALYSIS OF FOCAL ADHESION KINASE WITH A METHANESULFONAMIDE DIAMINOPYRIMIDINE INHIBITOR |
| 3C0G | A:94-322; B:94-324 | CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P1 FORM |
| 3C0H | A:94-304; B:94-304 | CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX, P1 FORM |
| 3C0I | A:94-303 | CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P212121 FORM |
| 3C13 | A:7-24,A:116-330 | LOW PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 |
| 3C1X | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOTRIAZINE BASED INHIBITOR |
| 3C4C | A:534-722; B:534-722 | B-RAF KINASE IN COMPLEX WITH PLX4720 |
| 3C4D | | [entry was replaced by entry 4FK3 without any CATH domain information] |
| 3C4E | A:125-305; B:125-305; C:125-305; D:125-305 | PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7-AZAINDOLE |
| 3C4F | A:564-759; B:564-759 | FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-METHOXYBENZYL)-7-AZAINDOLE |
| 3C5U | A:111-319 | P38 ALPHA MAP KINASE COMPLEXED WITH A BENZOTHIAZOLE BASED INHIBITOR |
| 3C7Q | A:919-1166 | STRUCTURE OF VEGFR2 KINASE DOMAIN IN COMPLEX WITH BIBF1120 |
| 3CBL | A:643-821 | CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE |
| 3CC6 | A:505-687 | CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B) |
| 3CCN | A:1160-1346 | X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR. |
| 3CD3 | A:643-821 | CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE |
| 3CD8 | A:1160-1346 | X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR. |
| 3CE3 | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOPYRIDINEPYRIDONE BASED INHIBITOR |
| 3CGF | A:151-370 | IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING |
| 3CGO | A:151-363 | IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING |
| 3CIK | A:276-494 | HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS |
| 3CJF | A:917-1164 | CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE |
| 3CJG | A:917-1164 | CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE |
| 3CKW | A:87-283 | CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24) |
| 3CKX | A:87-283 | CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24) IN COMPLEX WITH STAUROSPORINE |
| 3CLY | A:1567-1762 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION |
| 3COH | A:217-387; B:217-387 | CRYSTAL STRUCTURE OF AURORA-A IN COMPLEX WITH A PENTACYCLIC INHIBITOR |
| 3COI | A:112-319 | CRYSTAL STRUCTURE OF P38DELTA KINASE |
| 3COK | A:95-265; B:95-265 | CRYSTAL STRUCTURE OF PLK4 KINASE |
| 3COM | B:105-300; A:105-298 | CRYSTAL STRUCTURE OF MST1 KINASE |
| 3CP9 | A:919-1166; B:919-1165 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR |
| 3CPB | A:919-1166; B:919-1165 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR |
| 3CPC | A:919-1166; B:919-1165 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR |
| 3CQU | A:234-428 | CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR |
| 3CQW | A:234-428 | CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR |
| 3CS9 | A:318-500; B:318-498; C:318-497; D:318-500 | HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB |
| 3CTH | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR |
| 3CTJ | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR |
| 3D4Q | A:534-723; B:534-723 | PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE |
| 3D7T | B:341-526; A:269-445 | STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK |
| 3D7Z | A:111-319 | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR |
| 3D94 | A:1052-1253 | CRYSTAL STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE IN COMPLEX WITH PQIP |
| 3D9V | A:160-358; B:160-358 | CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI-METHYLATED VARIANT OF FASUDIL |
| 3DA6 | A:151-365 | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-METHYL-4-(3-(2-(METHYLAMINO)PYRIMIDIN-4-YL)PYRIDIN-2-YLOXY) NAPHTHALEN-1-YL)-1H-BENZO[D]IMIDAZOL-2-AMINE |
| 3DDP | A:85-295; C:85-295 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8 |
| 3DDQ | A:85-295; C:85-294 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE |
| 3DFC | B:106-291 | CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP |
| 3DGK | A:106-292 | CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN |
| 3DKC | A:1160-1362 | STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH ATP |
| 3DKF | A:1160-1361 | STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523 |
| 3DKG | A:1160-1356 | STRUCTURE OF MUTANT(Y1248L) MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523 |
| 3DKO | A:714-902 | COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7 |
| 3DOG | A:85-295; C:85-294 | STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1 |
| 3DPK | A:666-910 | CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR |
| 3DS6 | A:111-319; B:111-319; C:111-319; D:111-319 | P38 COMPLEX WITH A PHTHALAZINE INHIBITOR |
| 3DT1 | A:111-319 | P38 COMPLEXED WITH A QUINAZOLINE INHIBITOR |
| 3DTC | A:225-405 | CRYSTAL STRUCTURE OF MIXED-LINEAGE KINASE MLK1 COMPLEXED WITH COMPOUND 16 |
| 3DTW | A:919-1166; B:919-1166 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR |
| 3E3B | X:8-25,X:117-334 | CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2ALPHA PRIME WITH A POTENT INDAZOLE-DERIVATIVE INHIBITOR |
| 3E62 | A:932-1128 | FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS |
| 3E63 | A:932-1128 | FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS |
| 3E64 | A:932-1128 | FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS |
| 3E7O | B:113-332; A:113-332 | CRYSTAL STRUCTURE OF JNK2 |
| 3E87 | A:236-429; B:236-429 | CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS |
| 3E88 | A:236-429; B:236-429 | CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS |
| 3E8D | A:236-429; B:236-429 | CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS |
| 3E92 | A:111-319 | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR |
| 3E93 | A:111-319 | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR |
| 3EFJ | A:1160-1351; B:1160-1351 | STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7 |
| 3EFK | A:1160-1351; B:1160-1351 | STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50 |
| 3EFW | B:217-387; A:217-387 | STRUCTURE OF AURORAA WITH PYRIDYL-PYRIMIDINE UREA INHIBITOR |
| 3EH9 | A:106-291 | CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP |
| 3EHA | A:106-291 | CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP |
| 3EID | A:85-296; C:85-296 | CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR |
| 3EJ1 | A:85-296; C:85-296 | CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR |
| 3EKK | A:1079-1282 | INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR |
| 3EKN | A:1079-1283 | INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR |
| 3ELJ | A:113-332 | JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR. |
| 3EQB | A:147-382 | X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP |
| 3EQP | B:208-392; A:208-390 | CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95 |
| 3EQR | A:208-392; B:208-390 | CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74 |
| 3ET7 | A:505-687 | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841 |
| 3ETA | B:1079-1283; A:1079-1283 | KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR |
| 3EYG | A:959-1154 | CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES |
| 3EYH | A:959-1154 | CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES |
| 3EZR | A:85-296 | CDK-2 WITH INDAZOLE INHIBITOR 17 BOUND AT ITS ACTIVE SITE |
| 3EZV | A:85-296 | CDK-2 WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE |
| 3F2A | A:125-308 | CRYSTAL STRUCTURE OF HUMAN PIM-1 IN COMPLEX WITH DAPPA |
| 3F5G | A:106-291 | CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+ |
| 3F5P | C:1079-1279; E:1079-1279; F:1079-1279; G:1079-1279; A:1079-1279; H:1079-1279; B:1079-1279; D:1079-1279; M:1079-1279; I:1079-1279; R:1079-1279; S:1079-1279; T:1079-1279; J:1079-1279; K:1079-1279; L:1079-1279 | COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3-CYANOQUINOLINE INHIBITOR |
| 3F5U | A:106-291 | CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+ |
| 3F5X | A:85-296; C:85-296 | CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE |
| 3F66 | A:1160-1349; B:1160-1349 | HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR |
| 3F7Z | A:137-383; B:137-383 | X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR |
| 3F82 | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE |
| 3F88 | A:137-383; B:137-383 | GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX |
| 3FC2 | A:137-309 | PLK1 IN COMPLEX WITH BI6727 |
| 3FDN | A:217-394 | STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY |
| 3FE3 | A:135-324; B:135-324 | CRYSTAL STRUCTURE OF THE KINASE MARK3/PAR-1: T211A-S215A DOUBLE MUTANT |
| 3FHR | A:121-349 | HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3 (MK3)-INHIBITOR COMPLEX |
| 3FI2 | A:151-503 | CRYSTAL STRUCTURE OF JNK3 WITH AMINO-PYRAZOLE INHIBITOR, SR-3451 |
| 3FI3 | A:151-377 | CRYSTAL STRUCTURE OF JNK3 WITH INDAZOLE INHIBITOR, SR-3737 |
| 3FI4 | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO4499 |
| 3FKL | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO9552 |
| 3FKN | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO7125 |
| 3FKO | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3668 |
| 3FL4 | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO5634 |
| 3FLN | C:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH R1487 |
| 3FLQ | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((S)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN |
| 3FLS | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((R)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FLW | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH PAMAPIMOD |
| 3FLY | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-ISOPROPYLAMINO-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FLZ | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 8-METHYL-6-PHENOXY-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FME | A:133-333 | CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6 (MEK6) ACTIVATED MUTANT (S207D, T211D) |
| 3FMH | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((R)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FMJ | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 4-(5-METHYL-3-PHENYL-ISOXAZOL-4-YL)-PYRIMIDIN-2-YLAMINE |
| 3FMK | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((S)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FML | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6224 |
| 3FMM | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6226 |
| 3FMN | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO2530 |
| 3FPM | A:141-342 | CRYSTAL STRUCTURE OF A SQUARATE INHIBITOR BOUND TO MAPKAP KINASE-2 |
| 3FQE | A:451-639 | CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH YM193306 |
| 3FQH | A:451-634; B:451-633 | CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE |
| 3FQS | A:451-639 | CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R406 |
| 3FSF | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE |
| 3FSK | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6257 |
| 3FUP | A:932-1128; B:932-1128 | CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES |
| 3FV8 | A:151-702 | JNK3 BOUND TO PIPERAZINE AMIDE INHIBITOR, SR2774. |
| 3FWQ | A:7-24,A:116-331; B:7-24,B:116-331 | INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT |
| 3FXW | A:121-349 | HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3/INHIBITOR 2 COMPLEX |
| 3FXX | A:703-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYE[PTYR]IW |
| 3FY2 | A:704-904 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYEFIW |
| 3FYJ | X:141-364 | CRYSTAL STRUCTURE OF AN OPTIMZIED BENZOTHIOPHENE INHIBITOR BOUND TO MAPKAP KINASE-2 (MK-2) |
| 3FYK | X:141-364 | CRYSTAL STRUCTURE OF A BENZTHIOPHENE LEAD BOUND TO MAPKAP KINASE-2 (MK-2) |
| 3FZ1 | A:85-296 | CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2) |
| 3FZO | A:505-687 | CRYSTAL STRUCTURE OF PYK2-APO, PROLINE-RICH TYROSINE KINASE |
| 3FZP | A:505-687 | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS |
| 3FZR | A:505-687 | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396 |
| 3FZS | A:505-687 | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796 |
| 3FZT | A:505-687 | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433 |
| 3G0E | A:673-931 | KIT KINASE DOMAIN IN COMPLEX WITH SUNITINIB |
| 3G0F | A:673-924; B:673-924 | KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB |
| 3G2F | B:284-513; A:284-510 | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE II (BMPR2) AT 2.35 A RESOLUTION |
| 3G33 | A:103-299; C:103-299 | CRYSTAL STRUCTURE OF CDK4/CYCLIN D3 |
| 3G90 | X:151-370 | JNK-3 BOUND TO (Z)-5-FLUORO-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL) METHYL)-3-(HYDROXYIMINO)INDOLIN-2-ONE |
| 3G9L | X:151-370 | JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-STYRYLINDOLIN-2-ONE |
| 3G9N | A:107-326 | JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-PHENYLINDOLIN-2-ONE |
| 3GB2 | A:137-383 | GSK3BETA INHIBITOR COMPLEX |
| 3GC7 | A:111-319 | THE STRUCTURE OF P38ALPHA IN COMPLEX WITH A DIHYDROQUINAZOLINONE |
| 3GC8 | A:111-319; B:111-319 | THE STRUCTURE OF P38BETA C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE |
| 3GC9 | A:111-319; B:111-319 | THE STRUCTURE OF P38BETA C119S, C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR |
| 3GCP | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH SB203580 |
| 3GCQ | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL45 |
| 3GCS | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH SORAFENIB |
| 3GCU | B:111-319; A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL48 |
| 3GCV | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL62 |
| 3GEN | A:477-658 | THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON'S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND |
| 3GFE | A:111-319 | CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDINONE INHIBITOR |
| 3GI3 | A:111-319 | CRYSTAL STRUCTURE OF A N-PHENYL-N'-NAPHTHYLUREA ANALOG IN COMPLEX WITH P38 MAP KINASE |
| 3GOK | B:141-342; E:141-342; H:141-342; K:141-342; G:141-342; A:141-342; C:141-342; F:141-342; I:141-342; L:141-342; D:141-342; J:141-342 | BINDING SITE MAPPING OF PROTEIN LIGANDS |
| 3GP0 | A:111-319 | CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 11 (P38 BETA) IN COMPLEX WITH NILOTINIB |
| 3GQI | A:564-759 | CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES |
| 3GQL | A:564-759; B:564-759; C:564-759 | CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES |
| 3GXL | A:85-298 | ALK-5 KINASE COMPLEX WITH GW857175 |
| 3H0Y | A:217-387 | AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE |
| 3H0Z | A:217-387; B:217-387; C:217-387 | AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE |
| 3H10 | A:217-387; B:217-387; D:217-387 | AURORA A INHIBITOR COMPLEX |
| 3H30 | A:7-24,A:116-334; B:7-24,B:116-334 | CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE |
| 3H9O | A:166-357 | PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK-1) IN COMPLEX WITH COMPOUND 9 |
| 3H9R | A:288-499 | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN |
| 3HA6 | A:217-387 | CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10 |
| 3HA8 | A:111-319 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/COMPOUND 14B |
| 3HDM | A:183-372 | CRYSTAL STRUCTURE OF SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH COMPOUND 1 |
| 3HDN | A:183-372 | CRYSTAL STRUCTURE OF SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH COMPOUND 2 |
| 3HEC | A:111-319 | P38 IN COMPLEX WITH IMATINIB |
| 3HEG | A:111-319 | P38 IN COMPLEX WITH SORAFENIB |
| 3HL7 | A:110-318 | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH SD-0006 |
| 3HLL | A:111-319 | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH PH-797804 |
| 3HMM | A:85-298 | STRUCTURE OF ALK5 + GW855857 |
| 3HNG | A:912-1158 | CRYSTAL STRUCTURE OF VEGFR1 IN COMPLEX WITH N-(4-CHLOROPHENYL)-2-((PYRIDIN-4-YLMETHYL)AMINO)BENZAMIDE |
| 3HP2 | A:111-319 | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIDINONE COMPOUND |
| 3HP5 | A:111-319 | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIMIDOPYRIDAZINONE COMPOUND |
| 3HRB | A:111-319 | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 3HRC | A:166-357 | CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ATP |
| 3HUB | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH SCIOS-469 |
| 3HUC | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL40 |
| 3HV3 | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL49 |
| 3HV4 | A:111-319; B:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL51 |
| 3HV5 | A:111-319; B:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL24 |
| 3HV6 | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL39 |
| 3HV7 | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH RL38 |
| 3HVC | A:111-319 | CRYSTAL STRUCTURE OF HUMAN P38ALPHA MAP KINASE |
| 3I4B | A:137-382; B:137-382 | CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR |
| 3I5N | A:1160-1346 | CRYSTAL STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR 13 |
| 3I5Z | A:106-336 | CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-N-(2-HYDROXY-1-PHENYLETHYL)-4-(5-METHYL-2-(PHENYLAMINO)PYRIMIDIN-4-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 3I60 | A:106-336 | CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5-METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2-CARBOXAMIDE |
| 3I81 | A:1049-1249 | CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH BMS-754807 [1-(4-((5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO)PYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL)-N-(6-FLUORO-3-PYRIDINYL)-2-METHYL-L-PROLINAMIDE] |
| 3IDP | B:534-720; A:534-720 | B-RAF V600E KINASE DOMAIN IN COMPLEX WITH AN AMINOISOQUINOLINE INHIBITOR |
| 3IG7 | A:85-296 | NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFP WITH CDK-2 |
| 3IGG | A:85-296 | NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFQ WITH CDK-2 |
| 3II5 | A:533-719; B:533-720 | THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR |
| 3IO7 | A:932-1128 | 2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2 |
| 3IOK | A:932-1128 | 2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2 |
| 3ION | A:166-357 | PDK1 IN COMPLEX WITH COMPOUND 8H |
| 3IOP | A:166-357 | PDK-1 IN COMPLEX WITH THE INHIBITOR COMPOUND-8I |
| 3IPH | A:111-319 | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH A BIPHENYLAMIDE INHIBITOR |
| 3ITZ | A:111-319 | CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDAZINE INHIBITOR |
| 3IW4 | A:424-617; C:424-617; B:424-617 | CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071 |
| 3IW5 | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH AN INDOLE DERIVATIVE |
| 3IW6 | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH A BENZYLPIPERAZIN-PYRROL |
| 3IW7 | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH AN IMIDAZO-PYRIDINE |
| 3IW8 | A:111-319 | STRUCTURE OF INACTIVE HUMAN P38 MAP KINASE IN COMPLEX WITH A THIAZOLE-UREA |
| 3JPV | A:125-305 | CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A PYRROLO[2,3-A]CARBAZOLE LIGAND |
| 3JS2 | A:564-759; B:564-759 | CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID |
| 3JUH | A:7-24,A:116-331; B:7-24,B:116-331 | CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY |
| 3JXW | A:125-306 | DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS |
| 3JY0 | A:125-307 | DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS |
| 3JY9 | A:932-1128 | JANUS KINASE 2 INHIBITORS |
| 3JYA | A:125-306 | DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS |
| 3K3I | A:111-319 | P38ALPHA BOUND TO NOVEL DGF-OUT COMPOUND PF-00215955 |
| 3K3J | A:111-319 | P38ALPHA BOUND TO NOVEL DFG-OUT COMPOUND PF-00416121 |
| 3KA0 | A:141-364 | MK2 COMPLEX WITH INHIBITOR 6-(5-(2-AMINOPYRIMIDIN-4-YLAMINO)-2-HYDROXYPHENYL)-N-METHYLBENZO[B]THIOPHENE-2-CARBOXAMIDE |
| 3KB7 | A:137-309 | CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR |
| 3KC3 | F:141-342; E:141-342; B:141-342; L:141-342; A:141-342; H:141-342; I:141-342; J:141-342; K:141-342; C:141-342; G:141-342; D:141-342 | MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE |
| 3KCF | B:285-501; A:285-500; C:285-500; D:285-500; E:285-500 | CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR |
| 3KCK | A:932-1128 | A NOVEL CHEMOTYPE OF KINASE INHIBITORS |
| 3KF7 | A:111-319 | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A TRIAZOLOPYRIMIDINE COMPOUND |
| 3KGA | A:141-364 | CRYSTAL STRUCTURE OF MAPKAP KINASE 2 (MK2) COMPLEXED WITH A POTENT 3-AMINOPYRAZOLE ATP SITE INHIBITOR |
| 3KN5 | A:462-482,A:501-729; B:462-482,B:501-729 | CRYSTAL STRUCTURE OF THE C-TERMINAL KINASE DOMAIN OF MSK1 IN COMPLEX WITH AMP-PNP |
| 3KN6 | A:462-482,A:501-729; B:462-482,B:501-729 | CRYSTAL STRUCTURE OF THE C-TERMINAL KINASE DOMAIN OF MSK1 |
| 3KQ7 | A:111-319 | STRUCTURE OF HUMAN P38ALPHA WITH N-[4-METHYL-3-(6-{[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]AMINO}PYRIDINE-3-AMIDO)PHENYL]-2-(MORPHOLIN-4-YL)PYRIDINE-4-CARBOXAMIDE |
| 3KRW | A:276-494 | HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK) |
| 3KRX | A:276-494 | HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL) |
| 3KUL | B:716-899; A:716-900 | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8) |
| 3KVX | A:151-366 | JNK3 BOUND TO AMINOPYRIMIDINE INHIBITOR, SR-3562 |
| 3KXX | A:564-759; B:564-759; C:564-759; D:564-759 | STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1 |
| 3KY2 | A:564-759; B:564-759 | CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN |
| 3L1S | B:137-382; A:137-382 | 3-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3 |
| 3L8S | A:111-319 | HUMAN P38 MAP KINASE IN COMPLEX WITH CP-547632 |
| 3L8V | A:1160-1357 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A BIARYLAMINE BASED INHIBITOR |
| 3L8X | A:111-319 | P38 ALPHA KINASE COMPLEXED WITH A PYRAZOLO-PYRIMIDINE BASED INHIBITOR |
| 3LAU | A:217-387 | CRYSTAL STRUCTURE OF AURORA2 KINASE IN COMPLEX WITH A GSK3BETA INHIBITOR |
| 3LB7 | | [entry was replaced by entry 3OMV without any CATH domain information] |
| 3LCD | A:666-910 | INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R |
| 3LCK | A:319-500 | THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) |
| 3LFN | A:85-296 | CRYSTAL STRUCTURE OF CDK2 WITH SAR57, AN AMINOINDAZOLE TYPE INHIBITOR |
| 3LFQ | A:85-296 | CRYSTAL STRUCTURE OF CDK2 WITH SAR60, AN AMINOINDAZOLE TYPE INHIBITOR |
| 3LFS | A:85-296 | CRYSTAL STRUCTURE OF CDK2 WITH SAR37, AN AMINOINDAZOLE TYPE INHIBITOR |
)
)